Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy

Open access
Cao, Bo, Qi, Yanfeng, Zhang, Guanyi, Xu, Duo, Zhan, Yang, Alvarez, Xavier, Guo, Zhiyong, Fu, Xueqi, Plymate, Stephen R., Sartor, Oliver, Zhang, Haitao, Dong, Yan·2014·Oncotarget

Abstract

// Bo Cao 1,2,* , Yanfeng Qi 1,* , Guanyi Zhang 2,3 , Duo Xu 1,2 , Yang Zhan 1 , Xavier Alvarez 4 , Zhiyong Guo 5 , Xueqi Fu 2 , Stephen R. Plymate 6,7 , Oliver Sartor 8,9 , Haitao Zhang 2,3 , and Yan Dong 1,10 1 Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA 2 College of Life Sciences, Jilin University, China 3 Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA 4 Tulane National Primate Research Center, Covington, LA 5 Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 6 Departments of Medicine, University of Washington School of Medicine, Seattle, WA 7 Department of Urology, University of Washington School of Medicine, Seattle, WA 8 Department of Urology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA 9 Department of Medicine, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA 10 National Engineering Laboratory for AIDS Vaccine, College of Life Sciences, Jilin University, China * These authors contributed equally; in alphabetical order Correspondence: Yan Dong, Haitao Zhang, email: // Keywords : androgen receptor, splice variant, prostate cancer, castration resistance, enzalutamide Received : February 18, 2014 Accepted : March 2, 2014 Published : March 4, 2014 Abstract Upregulation of constitutively-active androgen receptor splice variants (AR-Vs) has been implicated in AR-driven tumor progression in castration-resistant prostate cancer. To date, functional studies of AR-Vs have been focused mainly on their ability to regulate gene expression independent of the full-length AR (AR-FL). Here, we showed that AR-V7 and AR v567es , two major AR-Vs, both facilitated AR-FL nuclear localization in the absence of androgen and mitigated the ability of the antiandrogen enzalutamide to inhibit AR-FL nuclear trafficking. AR-V bound to the promoter of its specific target without AR-FL, but co-occupied the promoter of canonical AR target with AR-FL in a mutually-dependent manner. AR-V expression attenuated both androgen and enzalutamide modulation of AR-FL activity/cell growth, and mitigated the in vivo antitumor efficacy of enzalutamide. Furthermore, AR v567es levels were upregulated in xenograft tumors that had acquired enzalutamide resistance. Collectively, this study highlights a dual function of AR-Vs in mediating castration resistance. In addition to trans-activating target genes independent of AR-FL, AR-Vs can serve as a “rheostat” to control the degree of response of AR-FL to androgen-directed therapy via activating AR-FL in an androgen-independent manner. The findings shed new insights into the mechanisms of AR-V-mediated castration resistance and have significant therapeutic implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1802

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 194

Metadata

Authors
Cao, B., Qi, Y., Zhang, G., Xu, D., Zhan, Y., Alvarez, X., Guo, Z., Fu, X., Plymate, S. R., Sartor, O., Zhang, H., & Dong, Y.
Venue
Oncotarget
Published
2014-03-04
Volume
5
Issue
6
Pages
1646-1656
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1848444843
Cited by
194
References
5
FWCI
22.05
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy. https://app.cochat.ai/papers/10.18632/oncotarget.1802
The paper
Cao, B., Qi, Y., Zhang, G., Xu, D., Zhan, Y., Alvarez, X., Guo, Z., Fu, X., Plymate, S. R., Sartor, O., Zhang, H., & Dong, Y. (2014). Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy. Oncotarget. https://doi.org/10.18632/oncotarget.1802

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.